Published in Neurourol Urodyn on January 01, 2002
Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nat Commun (2012) 1.74
Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc (2010) 1.62
Nocturia and disturbed sleep in the elderly. Sleep Med (2008) 1.47
Prevalence and correlates of nocturia in community-dwelling older men: results from the korean longitudinal study on health and aging. Korean J Urol (2012) 1.46
Promising molecular targets and biomarkers for male BPH and LUTS. Curr Urol Rep (2013) 1.43
Nocturia and overnight polysomnography in Parkinson disease. Neurourol Urodyn (2013) 1.40
Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan. BMC Res Notes (2015) 1.39
A systematic evaluation of factors associated with nocturia--the population-based FINNO study. Am J Epidemiol (2009) 1.29
Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics. Can Urol Assoc J (2008) 1.16
The effect of nocturia on sleep. Sleep Med Rev (2010) 1.05
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.02
Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment. Int Urogynecol J (2013) 1.01
Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis (2013) 0.98
Impact of nocturia on health-related quality of life and medical outcomes study sleep score in men. Int Neurourol J (2011) 0.93
Obstructive sleep apnea in a Danish population of men and women aged 60-80 years with nocturia. J Clin Sleep Med (2012) 0.91
Correlates of self-reported nocturia among community-dwelling older adults. J Gerontol A Biol Sci Med Sci (2009) 0.90
Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies. World J Urol (2014) 0.90
Nocturia: state of the art and critical analysis of current assessment and treatment strategies. World J Urol (2014) 0.86
Nocturia is associated with an increased risk of coronary heart disease and death. BJU Int (2012) 0.85
Age related change of nocturia in women. Int Neurourol J (2010) 0.85
Nocturia reported in nightly sleep diaries: common occurrence with significant implications? Health Psychol (2013) 0.84
Pathophysiology of overactive bladder. Int Urogynecol J (2012) 0.84
Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older. World J Urol (2014) 0.83
The effect of nocturia on sleep quality and daytime function in patients with lower urinary tract symptoms: a cross-sectional study. Clin Interv Aging (2016) 0.83
Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. J Korean Med Sci (2010) 0.83
Current evaluation and treatment of nocturia. Korean J Urol (2013) 0.83
Urodynamic assessment of urinary incontinence. Indian J Urol (2010) 0.82
Impact of stress urinary incontinence and overactive bladder on micturition patterns and health-related quality of life. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.82
Polypharmacy and incontinence. Z Gerontol Geriatr (2012) 0.81
Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality. Sleep Med (2014) 0.81
Practical management of nocturia in urology. Indian J Urol (2008) 0.80
α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume. World J Urol (2010) 0.80
Does the presenting bladder volume at urodynamics have any diagnostic relevance? Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.79
Strong impact of nocturia on sleep quality in patients with lower urinary tract symptoms. World J Mens Health (2012) 0.79
The burden of nocturia among middle-aged and older women. Obstet Gynecol (2015) 0.79
Presence of multiple peripheral circadian oscillators in the tissues controlling voiding function in mice. Exp Mol Med (2014) 0.79
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol (2007) 0.79
The Relations between Enuresis in Childhood and Nocturnal Polyuria Syndrome in Adult Life. Int Neurourol J (2012) 0.78
Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study. World J Urol (2014) 0.78
Effects of a Gentle, Self-Administered Stimulation of Perineal Skin for Nocturia in Elderly Women: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial. PLoS One (2016) 0.78
Nocturia is an independent predictor of severe obstructive sleep apnea in patients with ischemic stroke. J Neurol (2010) 0.78
Prevalence, impact on the quality of life and pathophysiological determinants of nocturia in urinary incontinent women. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.77
Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). World J Urol (2014) 0.77
The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study. Int Neurourol J (2015) 0.77
Nocturia: focus on etiology and consequences. Rev Urol (2012) 0.77
Age-Related Sleep Disruption and Reduction in the Circadian Rhythm of Urine Output: Contribution to Nocturia? Curr Aging Sci (2016) 0.76
Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies. World J Urol (2014) 0.75
The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate Int (2016) 0.75
Continuous positive airway pressure therapy is associated with improvement in overactive bladder symptoms in women with obstructive sleep apnea syndrome. Cent European J Urol (2016) 0.75
Impact of transobturator tape treatment on overactive bladder symptoms, particularly nocturia, in patients with mixed urinary incontinence. Korean J Urol (2014) 0.75
Medication adherence in the management of nocturia: challenges and solutions. Patient Prefer Adherence (2015) 0.75
Nocturia and disturbed sleep: where do we stand? J Clin Sleep Med (2013) 0.75
Frequent urination causing sleepless nights in a 64-year-old man. CMAJ (2014) 0.75
Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.75
Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. ScientificWorldJournal (2013) 0.75
Rapid Palatal Expansion to Treat Nocturnal Enuretic Children: a Systematic Review and Meta-Analysis. J Dent (Shiraz) (2015) 0.75
Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia. Cent European J Urol (2011) 0.75
Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort. J Clin Neurol (2013) 0.75
Nocturia: aetiology and treatment in adults. Nat Rev Urol (2016) 0.75
Testosterone Deficiency and Nocturia: A Review. World J Mens Health (2017) 0.75
Prevalence of obstructive sleep apnea detected by the Berlin Questionnaire in patients with nocturia attending a urogynecology unit. Int Urogynecol J (2015) 0.75
Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia. BMC Urol (2013) 0.75
The Prevalence of Nocturia and Nocturnal Polyuria: Can New Cutoff Values Be Suggested According to Age and Sex? Int Neurourol J (2016) 0.75
Nocturia: The circadian voiding disorder. Investig Clin Urol (2016) 0.75
Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study. Clin Exp Nephrol (2014) 0.75
A population-based study of factors associated with nocturia in reproductive-aged Turkish women. Korean J Urol (2014) 0.75
Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: A Cross-sectional, Population-based Study. Clin Ther (2016) 0.75
Combination therapies for the management of nocturia and its comorbidities. Res Rep Urol (2015) 0.75
The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia. World J Urol (2014) 0.75
Patients' Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day. Patient (2017) 0.75
Nocturia × disturbed sleep: a review. Int Urogynecol J (2011) 0.75
Fluid intake and voiding parameters in asymptomatic Turkish women. Int Urogynecol J (2012) 0.75
Nocturia: consequences, classification, and management. F1000Res (2017) 0.75
Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK. Eur J Health Econ (2016) 0.75
Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls. Int Urogynecol J (2012) 0.75
Influence of Daytime or Nighttime Dosing with Solifenacin for Overactive Bladder with Nocturia: Impact on Nocturia and Sleep Quality. J Korean Med Sci (2017) 0.75
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 22.80
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn (2002) 8.01
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol (2006) 7.13
ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn (2004) 5.31
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol (2008) 4.72
Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med (2003) 4.68
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol (2002) 4.31
Urodynamic features and artefacts. Neurourol Urodyn (2012) 3.78
Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy (2002) 3.42
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int (2011) 3.28
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. Clin Cancer Res (2010) 2.87
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol (2008) 2.58
Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol (2003) 2.46
Ethnicity, socio-economic position and gender--do they affect reported health-care seeking behaviour? Soc Sci Med (2003) 2.43
Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol (2008) 2.41
Sleep restriction is not associated with a positive energy balance in adolescent boys. Am J Clin Nutr (2012) 2.38
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol (2009) 2.33
Screening for prostate cancer. Lancet (2003) 2.24
'The public is too subjective': public involvement at different levels of health-care decision making. Soc Sci Med (2002) 2.19
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 2.14
Suicide and the internet. BMJ (2008) 2.13
A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients? J Urol (2006) 2.13
EAU guidelines on urinary incontinence. Eur Urol (2010) 2.10
The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement. Eur Urol (2007) 2.03
Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness. Contemp Clin Trials (2008) 2.00
The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol. Structure (2007) 1.99
Urethral pressure reflectometry before and after tension-free vaginal tape. Neurourol Urodyn (2012) 1.98
Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2003) 1.87
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol (2012) 1.81
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures. J Urol (2006) 1.77
The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol (2006) 1.77
'Questerviews': using questionnaires in qualitative interviews as a method of integrating qualitative and quantitative health services research. J Health Serv Res Policy (2004) 1.73
Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT. Cancer Res (2011) 1.71
How should patients with an overactive bladder manipulate their fluid intake? BJU Int (2008) 1.70
The International Consultation on Incontinence Modular Questionnaire: www.iciq.net. J Urol (2006) 1.69
Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract? J Urol (2010) 1.67
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet (2010) 1.67
Common variants in P2RY11 are associated with narcolepsy. Nat Genet (2010) 1.65
A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand (2004) 1.62
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Noninvasive techniques for the measurement of isovolumetric bladder pressure. J Urol (2004) 1.58
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
Factors associated with change in pain and disability over time: a community-based prospective observational study of hip and knee osteoarthritis. Br J Gen Pract (2005) 1.55
Recognising and responding to suicidal crisis within family and social networks: qualitative study. BMJ (2011) 1.52
Risk of tape-related complications after TVT is at least 4%. Neurourol Urodyn (2010) 1.52
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int (2006) 1.50
The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG (2002) 1.50
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence. Int Urogynecol J (2012) 1.50
Validity of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms: a screening questionnaire for children. J Urol (2010) 1.48
Treatment options for residual insomnia in schizophrenia. Acta Psychiatr Scand (2012) 1.47
Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep (2010) 1.47
Automatic evaluation of ultrasonography-estimated bladder weight and bladder wall thickness in community-dwelling men with presumably normal bladder function. BJU Int (2011) 1.45
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Can maximum urethral closure pressure (MUCP) be used to predict outcome of surgical treatment of stress urinary incontinence? Neurourol Urodyn (2011) 1.44
Pelvic floor muscle training in the prevention and treatment of urinary incontinence in women - what is the evidence? Acta Obstet Gynecol Scand (2008) 1.43
Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J Biotechnol (2006) 1.43
Risk of stress urinary incontinence twelve years after the first pregnancy and delivery. Obstet Gynecol (2006) 1.42
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol (2011) 1.42
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord (2012) 1.42
The impact of tension-free vaginal tape on the urethral closure function: mechanism of action. Neurourol Urodyn (2013) 1.41
What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trial. Int Urogynecol J (2011) 1.41
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Flow meter urine testing: a practical proposition in patients attending for urodynamics? BJU Int (2006) 1.40
Family history of idiopathic REM behavior disorder: a multicenter case-control study. Neurology (2013) 1.39
Obesity and urinary incontinence. Menopause Int (2008) 1.39
The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study. Eur J Obstet Gynecol Reprod Biol (2011) 1.39
The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer. Int J Gynecol Cancer (2013) 1.39
Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int (2006) 1.37
Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn (2010) 1.36
In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology (2008) 1.34
Tryptophan catabolism and T cell responses. Adv Exp Med Biol (2003) 1.34
Explaining non-help-seeking amongst young adults with mental distress: a dynamic interpretive model of illness behaviour. Sociol Health Illn (2007) 1.31
Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep (2012) 1.28
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn (2008) 1.26
Tuberculosis transmission and use of methamphetamines in Snohomish County, WA, 1991-2006. Am J Public Health (2010) 1.24
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG (2004) 1.24
Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn (2005) 1.23
A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol (2004) 1.23
Surgical treatment of stress incontinence in men. Neurourol Urodyn (2010) 1.23
Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol (2007) 1.19
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Qualitative research to improve RCT recruitment: issues arising in establishing research collaborations. Contemp Clin Trials (2008) 1.17
Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG (2004) 1.17
A qualitative study of help seeking and primary care consultation prior to suicide. Br J Gen Pract (2005) 1.14
Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol (2008) 1.14
Hip-preserving surgery: understanding complex pathomorphology. J Bone Joint Surg Am (2009) 1.13
Using qualitative research methods to improve recruitment to randomized controlled trials: the Quartet study. J Health Serv Res Policy (2008) 1.12
Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol (2006) 1.12
Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int (2008) 1.12
Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus. Diabetes Res Clin Pract (2012) 1.12